Rebimastat (BMS-275291)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 00:34, 3 December 2022 by Jwarner (talk | contribs) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bms-275291 NCI Drug Dictionary]: A substance that is being studied in the t...")

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

From the NCI Drug Dictionary: A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called matrix metalloproteinase inhibitors (MMPIs).

Retrieved from "https://hemonc.org/w/index.php?title=Rebimastat_(BMS-275291)&oldid=64857"